Clinically, a patient with malignant pleural mesothelioma was treated with anti-FAP ΔCD28/CD3ζ CAR T cells and experienced stable disease for 1 year, suggesting that ΔCD28/CD3ζ CAR T cells may have contributed in controlling his disease (147). Here, CD247 is linked to malignant pleural mesothelioma.